TY  - GEN
AU  - Sacchi,S
AU  - Kantarjian,H M
AU  - Freireich,E J
AU  - O'Brien,S
AU  - Cortes,J
AU  - Rios,M B
AU  - Kornblau,S
AU  - Giles,F J
AU  - Koller,C
AU  - Gajewski,J
AU  - Talpaz,M
TI  - Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia
SN  - 1042-8194
PY  - 2000///0214
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Ataxia
KW  - chemically induced
KW  - Combined Modality Therapy
KW  - adverse effects
KW  - Cytarabine
KW  - Drug Administration Schedule
KW  - Female
KW  - Femur Head Necrosis
KW  - Humans
KW  - Immunologic Factors
KW  - Interferon-alpha
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Leukocytosis
KW  - Life Tables
KW  - Male
KW  - Middle Aged
KW  - Paranoid Disorders
KW  - Pilot Projects
KW  - Pseudotumor Cerebri
KW  - Pulmonary Edema
KW  - Red-Cell Aplasia, Pure
KW  - Remission Induction
KW  - Survival Analysis
KW  - Syncope
KW  - Treatment Outcome
KW  - Tretinoin
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1080/10428199909169612
ER  -